Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Clinical trial NCT01539590 · TERMINATED
Trial details
- NCT number
- NCT01539590
- Sponsor
- Angion Biomedica Corp
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.